Patient Capital Management’s ProShares Ultra Bloomberg Crude Oil UCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-10,000
Closed -$419K 44
2022
Q2
$419K Buy
+10,000
New +$442K 0.19% 41

Other funds holding UCO

Patient Capital Management's UCO Position: Q3 2022 in Review

Patient Capital Management sold out of ProShares Ultra Bloomberg Crude Oil (UCO) in Q3 2022, closing a stake of 10,000 shares — an estimated $419K sold.

Patient Capital Management first reported a position in UCO in Q2 2022 and held it in 1 quarter. The position peaked at $419K in Q2 2022. 47 funds tracked by Wall St. Rank hold UCO as of Q3 2022.

  • Patient Capital Management reported no remaining ProShares Ultra Bloomberg Crude Oil position as of Q3 2022 after selling out during the quarter.
  • Patient Capital Management sold 10,000 ProShares Ultra Bloomberg Crude Oil shares in Q3 2022, an estimated $419K.
  • Patient Capital Management first reported a position in ProShares Ultra Bloomberg Crude Oil in Q2 2022 and held it in 1 quarter.
  • Patient Capital Management's ProShares Ultra Bloomberg Crude Oil position peaked at $419K in Q2 2022.
  • 47 funds tracked by Wall St. Rank held ProShares Ultra Bloomberg Crude Oil as of Q3 2022.

Based on Patient Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.